4.8 Article

Remodeling of Mitochondrial Metabolism by a Mitochondria-Targeted RNAi Nanoplatform for Effective Cancer Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Engineering, Biomedical

Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy

Shuwen Cao et al.

Summary: This study identified MGLL and CB-2 as over-expressed enzymes in PAC cells and receptors on TAMs, respectively. By developing a reduction-responsive nanoplatform for co-delivery of siMGLL and siCB-2, the researchers were able to achieve concurrent suppression of FFAs generation in PAC cells and repolarization of TAMs into tumor-inhibiting M1-like phenotype, leading to a combinational anticancer effect.

BIOMATERIALS (2022)

Review Genetics & Heredity

Drug delivery systems for RNA therapeutics

Kalina Paunovska et al.

Summary: This article provides an overview of the importance of RNA-based gene therapy and describes the molecular mechanisms of RNA therapies and different drug delivery systems. It also discusses the path from preclinical research to clinical approval for these therapies.

NATURE REVIEWS GENETICS (2022)

Review Cell Biology

Rewiring cell signalling pathways in pathogenic mtDNA mutations

Chih-Yao Chung et al.

Summary: Mutations in mitochondrial DNA have a significant impact on cellular energy homeostasis and signaling pathways, influencing disease presentation and progression.

TRENDS IN CELL BIOLOGY (2022)

Review Nanoscience & Nanotechnology

Organelle-level precision with next-generation targeting technologies

Anand Saminathan et al.

Summary: Intracellular organelles are subsystems within a cell that reflect the metabolic state of the cell, and biological pathways can be exploited to target exogenous cargo to specific organelles with nucleic acids as suitable delivery vehicles.

NATURE REVIEWS MATERIALS (2022)

Article Medicine, Research & Experimental

Targeting mitochondria in cancer therapy: Insight into photodynamic and photothermal therapies

Jamileh Kadkhoda et al.

Summary: Mitochondria play critical roles in cellular functioning and cell death. Targeting mitochondria in cancer treatment shows promise in regulating cancer cell death through affecting mitochondrial signaling pathways.

LIFE SCIENCES (2022)

Review Medicine, Research & Experimental

Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases

Timofei Chernega et al.

Summary: This article investigates the current treatment options for mitochondrial diseases and explores the potential of RNA-based therapeutic strategies, including the use of ASOs and RNAi drugs, allotopic therapies, and RNA-based antigenomic therapies. Furthermore, various mechanisms for delivering RNA therapeutic agents to the mitochondrial matrix are reviewed.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Review Oncology

Mitochondrial DNA is a major source of driver mutations in cancer

Minsoo Kim et al.

Summary: This article discusses the role of mitochondrial DNA mutations in tumors, emphasizing their direct impact on metabolic homeostasis. The contentious nature of this impact has been clarified by recent studies, revealing the importance of mutations in cancer initiation and progression.

TRENDS IN CANCER (2022)

Review Biochemistry & Molecular Biology

Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

Jingjing Yang et al.

Summary: This article comprehensively discusses the history and recent advances in targeted therapies on organelles, with a focus on organelle structures, organelle-mediated cell death signal pathways, and design guidelines of organelle-targeted nanomedicines based on intervention mechanisms. Furthermore, it presents a perspective on future research and clinical opportunities in precision oncology.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Chemistry, Multidisciplinary

Nanocatalytic Innate Immunity Activation by Mitochondrial DNA Oxidative Damage for Tumor-Specific Therapy

Han Jiang et al.

Summary: A novel tumor immunotherapy modality based on nanocatalytic innate immunity activation by inducing oxidative damage in tumor cells' mtDNA is proposed. This approach reactivates macrophages' immune response against cancer cells, leading to the inhibition of primary and distant tumor growth during treatment.

ADVANCED MATERIALS (2021)

Review Oncology

High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy

Marco Fiorillo et al.

Summary: The study suggests that high mitochondrial ATP production is a new therapeutic target for cancer treatment, isolating metabolically fit cancer cells with enhanced stem-like properties and invasive abilities. By regulating mitochondrial ATP-synthase, prevention of metastasis in cancer cells is possible.

FRONTIERS IN ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy

Lei Xu et al.

Summary: This study developed a nanoparticle platform targeting tumor cells for effective breast cancer therapy by inhibiting mitochondrial glutaminolysis and employing chemodynamic therapy. The approach involves targeting and releasing specific substances to disrupt tumor cell metabolism and redox balance, ultimately inhibiting tumor growth.

NANO LETTERS (2021)

Review Oncology

Defueling the cancer: ATP synthase as an emerging target in cancer therapy

Ting Wang et al.

Summary: Reprogramming of cellular metabolism is a hallmark of cancer, with high expression of ATP synthase playing a role. ATP synthase is involved in angiogenesis, tumorigenesis, and metastasis of cancer.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Review Chemistry, Multidisciplinary

Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment

Jingbo Qin et al.

Summary: This review summarizes the state of the art of design and construction of nanosystems used for mitochondria-targeted delivery in cancer treatment. It discusses the use of nanotechnology through various pathways such as energy metabolism interference, ROS regulation, mitochondrial protein targeting, mtDNA interference, mitophagy inducing, and combination therapy. Finally, it provides an overview of the major challenges and future prospects in this field.

NANOSCALE (2021)

Article Biochemical Research Methods

Mitochondria-specific delivery system for targeted regulation of mitochondrial gene expression

Shicheng Su et al.

Summary: This protocol describes the design and preparation of an NP platform for mitochondria-specific gene delivery, which can be used in mice to deliver nucleic acid therapeutics and treat mitochondria-regulated diseases.

STAR PROTOCOLS (2021)

Review Biochemistry & Molecular Biology

The Mitochondrion as an Emerging Therapeutic Target in Cancer

Katherine G. Roth et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Review Multidisciplinary Sciences

Metabolic reprogramming and cancer progression

Brandon Faubert et al.

SCIENCE (2020)

Review Cell Biology

Mitochondrial Metabolism as a Target for Cancer Therapy

Karthik Vasan et al.

CELL METABOLISM (2020)

Article Biochemistry & Molecular Biology

Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output

Qiyi Zhao et al.

Review Medicine, General & Internal

Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours

Sonia Missiroli et al.

EBIOMEDICINE (2020)

Review Biotechnology & Applied Microbiology

The current state and future directions of RNAi-based therapeutics

Ryan L. Setten et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Editorial Material Oncology

Targeting mitochondria as an anticancer strategy

Lanfeng Dong et al.

CANCER COMMUNICATIONS (2019)

Article Chemistry, Multidisciplinary

Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy

Xiaoding Xu et al.

Review Cell Biology

Mitochondrial metabolism and cancer

Paolo Ettore Porporato et al.

CELL RESEARCH (2018)

Article Biotechnology & Applied Microbiology

Overcoming cellular barriers for RNA therapeutics

Steven F. Dowdy

NATURE BIOTECHNOLOGY (2017)

Review Pharmacology & Pharmacy

Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective

Zhenjie Wang et al.

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Review Oncology

Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi et al.

NATURE REVIEWS CANCER (2017)

Review Chemistry, Multidisciplinary

Next-Generation Lipids in RNA Interference Therapeutics

Stephanie Rietwyk et al.

ACS NANO (2017)

Review Immunology

Mitochondrial DNA in innate immune responses and inflammatory pathology

A. Phillip West et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Pharmacology & Pharmacy

Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer

Yang Liu et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Review Chemistry, Multidisciplinary

Advancement of the Emerging Field of RNA Nanotechnology

Daniel Jasinski et al.

ACS NANO (2017)

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Review Biochemistry & Molecular Biology

Mitochondria and Cancer

Wei-Xing Zong et al.

MOLECULAR CELL (2016)

Article Biochemistry & Molecular Biology

Targeting mitochondria metabolism for cancer therapy

Samuel E. Weinberg et al.

NATURE CHEMICAL BIOLOGY (2015)

Review Biotechnology & Applied Microbiology

Clinical experiences with systemically administered siRNA-based therapeutics in cancer

Jonathan E. Zuckerman et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Multidisciplinary Sciences

Tissue-based map of the human proteome

Mathias Uhlen et al.

SCIENCE (2015)

Review Biotechnology & Applied Microbiology

Modulation of oxidative stress as an anticancer strategy

Chiara Gorrini et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Multidisciplinary Sciences

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug

Xiaoyang Xu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Genetics & Heredity

Human mitochondrial DNA: roles of inherited and somatic mutations

Eric A. Schon et al.

NATURE REVIEWS GENETICS (2012)

Review Oncology

Mitochondria and cancer

Douglas C. Wallace

NATURE REVIEWS CANCER (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Genetics & Heredity

State-of-the-art gene-based therapies: the road ahead

Mark A. Kay

NATURE REVIEWS GENETICS (2011)

Review Chemistry, Multidisciplinary

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

Katrin Knop et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)

Review Biotechnology & Applied Microbiology

Targeting mitochondria for cancer therapy

Simone Fulda et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Biotechnology & Applied Microbiology

Knocking down barriers: advances in siRNA delivery

Kathryn A. Whitehead et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Chemistry, Multidisciplinary

Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform

Liangfang Zhang et al.

ACS NANO (2008)

Review Cell Biology

The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation

Ralph J. DeBerardinis et al.

CELL METABOLISM (2008)

Review Pharmacology & Pharmacy

RNAi therapeutics: Principles, prospects and challenges

Lars Aagaard et al.

ADVANCED DRUG DELIVERY REVIEWS (2007)

Article Biochemistry & Molecular Biology

Internalization of cationic peptides: the road less (or more?) traveled

S. M. Fuchs et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2006)

Article Multidisciplinary Sciences

Delivery of bioactive molecules to mitochondria in vivo

RAJ Smith et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)